Anteris Technologies Ltd (ASX:AVR)
A$ 12.85 0.75 (6.2%) Market Cap: 271.63 Mil Enterprise Value: 263.55 Mil PE Ratio: 0 PB Ratio: 43.56 GF Score: 53/100

Anteris Technologies Ltd at NWR Healthcare Conference (Virtual) Transcript

Mar 20, 2023 / 09:40PM GMT
Release Date Price: A$18.69 (-1.89%)
Matt Wright
NWR Communications - Moderator

Hello, and welcome back to the NWR Virtual Healthcare Conference. My name is Matt Wright. Next up, we have Wayne Paterson, the CEO and Managing Director of Anteris Technologies, listed under the ASX ticker, AVR. Anteris Technologies is a structural heart company that delivers clinical superior and durable solutions through better science and design.

Before we hear from Wayne, a reminder that if anyone in the audience has a question, please feel free to type it in using the Q&A function within Zoom. I'll hand it over to Wayne. Please go ahead, Wayne.

Wayne Paterson
Anteris Technologies Ltd - MD and CEO

Thanks, Matt. Appreciate it. Good morning, everybody. I can't see you, but I know you're out there. So as Matt said, I'm Wayne Paterson, the CEO of Anteris Technologies. I'm going to talk a little bit about our company today, of course, and the disease state in which we operate in.

But, of course, as you know Anteris is an ASX listed company under the ticker of AVR. But what we've basically done

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot